• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自婴儿肠道常驻微生物群的双歧杆菌菌株具有抗菌活性。

Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.

作者信息

Liévin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser J R, Servin A L

机构信息

Institut National de la Santé et de la Recherche Médicale, Unité 510, UFR de Pharmacie, Université Paris XI, 92296 Châtenay-Malabry, France.

出版信息

Gut. 2000 Nov;47(5):646-52. doi: 10.1136/gut.47.5.646.

DOI:10.1136/gut.47.5.646
PMID:11034580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1728100/
Abstract

BACKGROUND AND AIMS

The gastrointestinal microflora exerts a barrier effect against enteropathogens. The aim of this study was to examine if bifidobacteria, a major species of the human colonic microflora, participates in the barrier effect by developing antimicrobial activity against enterovirulent bacteria.

METHODS

Antibacterial activity was examined in vitro against a wide range of Gram negative and Gram positive pathogens. Inhibition of Salmonella typhimurium SL1334 cell association and cell invasion was investigated in vitro using Caco-2 cells. Colonisation of the gastrointestinal tract in vivo by bifidobacteria was examined in axenic C3/He/Oujco mice. Antimicrobial activity was examined in vivo in axenic C3/He/Oujco mice infected by the lethal S typhimurium C5 strain.

RESULTS

Fourteen human bifidobacterium strains isolated from infant stools were examined for antimicrobial activity. Two strains (CA1 and F9) expressed antagonistic activity against pathogens in vitro, inhibited cell entry, and killed intracellular S typhimurium SL1344 in Caco-2 cells. An antibacterial component(s) produced by CA1 and F9 was found to be a lipophilic molecule(s) with a molecular weight of less than 3500. In the axenic C3/He/Oujco mice, CA1 and F9 strains colonised the intestinal tract and protected mice against S typhimurium C5 lethal infection.

CONCLUSION

Several bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity, suggesting that they could participate in the "barrier effect" produced by the indigenous microflora.

摘要

背景与目的

胃肠道微生物群对肠道病原体具有屏障作用。本研究旨在探讨双歧杆菌(人类结肠微生物群的主要菌种之一)是否通过产生针对肠道致病细菌的抗菌活性来参与屏障作用。

方法

在体外检测对多种革兰氏阴性和革兰氏阳性病原体的抗菌活性。使用Caco - 2细胞在体外研究对鼠伤寒沙门氏菌SL1334细胞黏附和细胞侵袭的抑制作用。在无菌C3/He/Oujco小鼠体内检测双歧杆菌在胃肠道的定植情况。在感染致死性鼠伤寒沙门氏菌C5菌株的无菌C3/He/Oujco小鼠体内检测抗菌活性。

结果

检测了从婴儿粪便中分离出的14株人类双歧杆菌菌株的抗菌活性。两株菌株(CA1和F9)在体外对病原体表现出拮抗活性,抑制细胞进入,并在Caco - 2细胞中杀死细胞内的鼠伤寒沙门氏菌SL1344。发现由CA1和F9产生的一种抗菌成分是分子量小于3500的亲脂性分子。在无菌C3/He/Oujco小鼠中,CA1和F9菌株在肠道定植,并保护小鼠免受鼠伤寒沙门氏菌C5致死性感染。

结论

来自婴儿胃肠道常驻微生物群的几株双歧杆菌菌株具有抗菌活性,表明它们可能参与了本土微生物群产生的“屏障作用”。

相似文献

1
Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.来自婴儿肠道常驻微生物群的双歧杆菌菌株具有抗菌活性。
Gut. 2000 Nov;47(5):646-52. doi: 10.1136/gut.47.5.646.
2
Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection.定殖于胃肠道的大肠杆菌菌株可保护无菌小鼠免受鼠伤寒沙门氏菌感染。
Gut. 2001 Jul;49(1):47-55. doi: 10.1136/gut.49.1.47.
3
Antagonistic activities of some Bifidobacterium sp. strains isolated from resident infant gastrointestinal microbiota on Gram-negative enteric pathogens.从婴儿肠道常驻微生物群中分离出的某些双歧杆菌菌株对革兰氏阴性肠道病原体的拮抗活性。
Anaerobe. 2016 Jun;39:39-44. doi: 10.1016/j.anaerobe.2016.02.010. Epub 2016 Feb 26.
4
Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB.黏附性嗜酸乳杆菌LB菌株的抗菌作用
Antimicrob Agents Chemother. 1997 May;41(5):1046-52. doi: 10.1128/AAC.41.5.1046.
5
Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces.从健康婴儿粪便中分离出的双歧杆菌和乳酸杆菌对艰难梭菌抗菌活性的鉴定与筛选。
Int J Antimicrob Agents. 2003 Apr;21(4):340-6. doi: 10.1016/s0924-8579(02)00389-8.
6
Screening of Bifidobacterium strains isolated from human faeces for antagonistic activities against potentially bacterial pathogens.从人类粪便中分离的双歧杆菌菌株对潜在细菌病原体的拮抗活性筛选。
Microbiol Res. 2003;158(2):179-85. doi: 10.1078/0944-5013-00192.
7
In vitro probiotic characteristics of Lactobacillus plantarum ZDY 2013 and its modulatory effect on gut microbiota of mice.植物乳杆菌ZDY 2013的体外益生菌特性及其对小鼠肠道微生物群的调节作用。
J Dairy Sci. 2015 Sep;98(9):5850-61. doi: 10.3168/jds.2014-9153. Epub 2015 Jul 2.
8
The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.人类嗜酸乳杆菌LA1菌株分泌一种在体外和体内均具有活性的非细菌素抗菌物质。
Appl Environ Microbiol. 1997 Jul;63(7):2747-53. doi: 10.1128/aem.63.7.2747-2753.1997.
9
Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages.小鼠腹腔巨噬细胞免疫激活后抗菌活性的不同变化。
J Immunol. 1987 Sep 1;139(5):1665-72.
10
Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria.悉生鹌鹑实验性坏死性小肠结肠炎中的梭菌致病性及双歧杆菌的保护作用
J Med Microbiol. 1998 May;47(5):391-9. doi: 10.1099/00222615-47-5-391.

引用本文的文献

1
Human gut microbiota-derived antimicrobials against Salmonella Typhi: diversity, mechanisms, and therapeutic potential.人肠道微生物群产生的抗伤寒沙门氏菌抗菌物质:多样性、作用机制及治疗潜力
Arch Microbiol. 2025 Aug 28;207(10):241. doi: 10.1007/s00203-025-04410-3.
2
Gut microbiome dysregulation in noninfectious uveitis.非感染性葡萄膜炎中的肠道微生物群失调
Front Immunol. 2025 Jul 29;16:1614304. doi: 10.3389/fimmu.2025.1614304. eCollection 2025.
3
The association of dietary iron intake and serum iron with fecal incontinence: results from NHANES 2007-2010.膳食铁摄入量和血清铁与大便失禁的关联:2007 - 2010年美国国家健康与营养检查调查结果
Front Nutr. 2025 Jun 19;12:1598172. doi: 10.3389/fnut.2025.1598172. eCollection 2025.
4
Anti-Obesity Properties of a Novel Probiotic Strain of CNTA 173 in .新型益生菌菌株CNTA 173的抗肥胖特性 于……
Int J Mol Sci. 2025 Apr 1;26(7):3286. doi: 10.3390/ijms26073286.
5
Health benefits, antimicrobial activities, and potential applications of probiotics: A review.益生菌的健康益处、抗菌活性及潜在应用:综述
Medicine (Baltimore). 2024 Dec 27;103(52):e32412. doi: 10.1097/MD.0000000000032412.
6
What Happens in the Gut during the Formation of Neonatal Jaundice-Underhand Manipulation of Gut Microbiota?肠道在新生儿黄疸形成过程中发生了什么——肠道微生物群的暗中操纵?
Int J Mol Sci. 2024 Aug 6;25(16):8582. doi: 10.3390/ijms25168582.
7
Molecular characteristics of fowl adenovirus strains detected in broiler chickens on diets without immunostimulant supplements.在未添加免疫刺激剂的日粮喂养的肉鸡中检测到的禽腺病毒毒株的分子特征
J Vet Res. 2024 May 20;68(2):207-214. doi: 10.2478/jvetres-2024-0028. eCollection 2024 Jun.
8
Evaluation of Safety and Beneficial Health Effects of the Human-Milk Strain DSM32583: An Infant Pilot Trial.人乳菌株DSM32583的安全性和有益健康效果评估:一项婴儿试点试验
Nutrients. 2024 Apr 11;16(8):1134. doi: 10.3390/nu16081134.
9
Research progress on the microbiota in bladder cancer tumors.膀胱癌肿瘤中微生物群的研究进展
Front Cell Infect Microbiol. 2024 Apr 8;14:1374944. doi: 10.3389/fcimb.2024.1374944. eCollection 2024.
10
Understanding the role of gut microfloral bifidobacterium in cancer and its potential therapeutic applications.了解肠道微生物双歧杆菌在癌症中的作用及其潜在的治疗应用。
Microbiome Res Rep. 2023 Oct 31;3(1):3. doi: 10.20517/mrr.2023.51. eCollection 2024.

本文引用的文献

1
Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB.嗜酸乳杆菌LB菌株对幽门螺杆菌感染的体内外拮抗活性
Appl Environ Microbiol. 1998 Nov;64(11):4573-80. doi: 10.1128/AEM.64.11.4573-4580.1998.
2
The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo.人类嗜酸乳杆菌LA1菌株分泌一种在体外和体内均具有活性的非细菌素抗菌物质。
Appl Environ Microbiol. 1997 Jul;63(7):2747-53. doi: 10.1128/aem.63.7.2747-2753.1997.
3
Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB.黏附性嗜酸乳杆菌LB菌株的抗菌作用
Antimicrob Agents Chemother. 1997 May;41(5):1046-52. doi: 10.1128/AAC.41.5.1046.
4
Modification of the intestinal microflora using probiotics and prebiotics.使用益生菌和益生元对肠道微生物群进行调节。
Scand J Gastroenterol Suppl. 1997;222:28-31. doi: 10.1080/00365521.1997.11720714.
5
Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection.干酪乳杆菌(菌株GG)在体外和体内对鼠伤寒沙门氏菌C5感染发挥的拮抗活性。
Appl Environ Microbiol. 1997 Feb;63(2):513-8. doi: 10.1128/aem.63.2.513-518.1997.
6
Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide.双歧杆菌培养上清液中的蛋白质因子,可阻止产肠毒素大肠杆菌与神经节四糖神经酰胺结合。
Appl Environ Microbiol. 1997 Feb;63(2):506-12. doi: 10.1128/aem.63.2.506-512.1997.
7
Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges.益生菌在稳定肠道黏膜屏障方面的临床应用:成功的菌株及未来挑战
Antonie Van Leeuwenhoek. 1996 Oct;70(2-4):347-58. doi: 10.1007/BF00395941.
8
Molecular analysis of the composition of the bifidobacterial and lactobacillus microflora of humans.人类双歧杆菌和乳酸菌微生物群组成的分子分析
Appl Environ Microbiol. 1996 Dec;62(12):4608-13. doi: 10.1128/aem.62.12.4608-4613.1996.
9
The indigenous gastrointestinal microflora.本土胃肠道微生物群落
Trends Microbiol. 1996 Nov;4(11):430-5. doi: 10.1016/0966-842x(96)10057-3.
10
Paneth cell defensins: endogenous peptide components of intestinal host defense.潘氏细胞防御素:肠道宿主防御的内源性肽成分。
FASEB J. 1996 Sep;10(11):1280-9. doi: 10.1096/fasebj.10.11.8836041.